ACE inhibitors and AT1R antagonists, often prescribed for conditions like hypertension, could potentially mitigate severe COVID-19 infection in dementia patients by preventing the cytokine storm and reducing the risk of end organ damage [20]. The gene discussed is ACE; the disease is Hypertension.